LevitasBio Overview
- Year Founded
-
2017
- Status
-
Private
- Employees
-
54
- Latest Deal Type
-
Series D
- Latest Deal Amount
-
$11.8M
- Investors
-
5
LevitasBio General Information
Description
Developer of a single-cell imaging and profiling platform designed to purify cells and nuclei without any markers or modifications. The company's platform utilises a groundbreaking cellular research and analysis method that allows scientists to examine, analyse, and understand biological signatures without altering, stressing, or damaging cells, all while preserving the original samples, enabling the life sciences market and healthcare industry to gain a deeper and more accurate understanding of biological processes.
Contact Information
Website
www.levitasbio.comCorporate Office
- 31057 Genstar Road
- Suit 137
- Hayward, CA 94544
- United States
Corporate Office
- 31057 Genstar Road
- Suit 137
- Hayward, CA 94544
- United States
LevitasBio Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Later Stage VC (Series D) | 10-Apr-2024 | $11.8M | Completed | Generating Revenue | ||
| 5. Later Stage VC (Series C) | 24-Oct-2022 | Completed | Generating Revenue | |||
| 4. Debt - General | 28-Jul-2021 | Completed | Generating Revenue | |||
| 3. Early Stage VC (Series B) | 13-Jan-2021 | Completed | Generating Revenue | |||
| 2. Early Stage VC | 08-Apr-2019 | Cancelled | Generating Revenue | |||
| 1. Early Stage VC (Series A) | 03-Aug-2017 | $8M | $8M | Completed | Generating Revenue |
LevitasBio Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series D | ||||||||
| Series C-1 | ||||||||
| Series C | ||||||||
| Series B-1 | ||||||||
| Series B | 14,048,803 | $0.000010 | 8% | $1.43 | $1.43 | 1x | $1.38 | 15.68% |
| Series A | 8,166,599 | $0.000010 | 8% | $0.98 | $0.98 | 1x | $0.98 | 8.8% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
LevitasBio Comparisons
Industry
Financing
Details
LevitasBio Competitors (26)
One of LevitasBio’s 26 competitors is Applied Cells, a Venture Capital-Backed company based in Santa Clara, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Applied Cells | Venture Capital-Backed | Santa Clara, CA | ||||
| Akadeum Life Sciences | Venture Capital-Backed | Ann Arbor, MI | ||||
| Personal Genome Diagnostics | Formerly VC-backed | Baltimore, MD | ||||
| Enrich Biosystems | Venture Capital-Backed | Branford, CT | ||||
| Standard BioTools | Formerly VC-backed | Boston, MA |
LevitasBio Patents
LevitasBio Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026006640-A1 | Particle separator system, materials, and methods of use | Pending | 26-Jun-2024 | ||
| WO-2026006640-A9 | Particle separator system, materials, and methods of use | Pending | 26-Jun-2024 | ||
| AU-2024234162-A1 | Particle separator system, materials, and methods of use | Pending | 13-Mar-2023 | ||
| EP-4680394-A1 | Particle separator system, materials, and methods of use | Pending | 13-Mar-2023 | ||
| US-20250271339-A1 | Particle separator system, materials, and methods of use | Pending | 13-Mar-2023 | C12M47/04 |
LevitasBio Signals
LevitasBio Investors (5)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Novalis LifeSciences | Venture Capital | Minority | ||
| StartX (US) | Accelerator/Incubator | Minority | ||
| The Pay It Forward Company | Venture Capital | Minority | ||
| Wuhan Thalys Medical Technology | Corporation | Minority | ||
| Decheng Capital | Venture Capital | Minority |
LevitasBio FAQs
-
When was LevitasBio founded?
LevitasBio was founded in 2017.
-
Where is LevitasBio headquartered?
LevitasBio is headquartered in Hayward, CA.
-
What is the size of LevitasBio?
LevitasBio has 54 total employees.
-
What industry is LevitasBio in?
LevitasBio’s primary industry is Discovery Tools (Healthcare).
-
Is LevitasBio a private or public company?
LevitasBio is a Private company.
-
What is the current valuation of LevitasBio?
The current valuation of LevitasBio is .
-
What is LevitasBio’s current revenue?
The current revenue for LevitasBio is .
-
How much funding has LevitasBio raised over time?
LevitasBio has raised $73.8M.
-
Who are LevitasBio’s investors?
Novalis LifeSciences, StartX (US), The Pay It Forward Company, Wuhan Thalys Medical Technology, and Decheng Capital have invested in LevitasBio.
-
Who are LevitasBio’s competitors?
Applied Cells, Akadeum Life Sciences, Personal Genome Diagnostics, Enrich Biosystems, and Standard BioTools are some of the 26 competitors of LevitasBio.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process